4//SEC Filing
Rubin Michael P. 4
Accession 0001415889-24-025393
CIK 0001736730other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:34 PM ET
Size
25.4 KB
Accession
0001415889-24-025393
Insider Transaction Report
Form 4
Northpond Ventures GP, LLC
10% Owner
Transactions
- Purchase
Common Stock
2024-10-15$11.00/sh+763,636$8,399,996→ 763,636 total(indirect: By Northpond Ventures III, LP) - Conversion
Series B Preferred Stock
2024-10-15−5,287,303→ 0 total(indirect: By Northpond Ventures, LP)→ Common Stock (471,415 underlying) - Conversion
Common Stock
2024-10-15+1,003,193→ 1,003,193 total(indirect: By Northpond Ventures II, LP) - Conversion
Common Stock
2024-10-15+471,415→ 471,415 total(indirect: By Northpond Ventures, LP) - Conversion
Series A Prime Preferred Stock
2024-10-15−11,251,624→ 0 total(indirect: By Northpond Ventures II, LP)→ Common Stock (1,003,193 underlying)
Northpond Ventures GP II, LLC
10% Owner
Transactions
- Conversion
Common Stock
2024-10-15+1,003,193→ 1,003,193 total(indirect: By Northpond Ventures II, LP) - Conversion
Common Stock
2024-10-15+471,415→ 471,415 total(indirect: By Northpond Ventures, LP) - Purchase
Common Stock
2024-10-15$11.00/sh+763,636$8,399,996→ 763,636 total(indirect: By Northpond Ventures III, LP) - Conversion
Series A Prime Preferred Stock
2024-10-15−11,251,624→ 0 total(indirect: By Northpond Ventures II, LP)→ Common Stock (1,003,193 underlying) - Conversion
Series B Preferred Stock
2024-10-15−5,287,303→ 0 total(indirect: By Northpond Ventures, LP)→ Common Stock (471,415 underlying)
Northpond Ventures, LP
10% Owner
Transactions
- Conversion
Common Stock
2024-10-15+1,003,193→ 1,003,193 total(indirect: By Northpond Ventures II, LP) - Purchase
Common Stock
2024-10-15$11.00/sh+763,636$8,399,996→ 763,636 total(indirect: By Northpond Ventures III, LP) - Conversion
Common Stock
2024-10-15+471,415→ 471,415 total(indirect: By Northpond Ventures, LP) - Conversion
Series A Prime Preferred Stock
2024-10-15−11,251,624→ 0 total(indirect: By Northpond Ventures II, LP)→ Common Stock (1,003,193 underlying) - Conversion
Series B Preferred Stock
2024-10-15−5,287,303→ 0 total(indirect: By Northpond Ventures, LP)→ Common Stock (471,415 underlying)
Northpond Ventures II, LP
10% Owner
Transactions
- Conversion
Common Stock
2024-10-15+1,003,193→ 1,003,193 total(indirect: By Northpond Ventures II, LP) - Conversion
Common Stock
2024-10-15+471,415→ 471,415 total(indirect: By Northpond Ventures, LP) - Purchase
Common Stock
2024-10-15$11.00/sh+763,636$8,399,996→ 763,636 total(indirect: By Northpond Ventures III, LP) - Conversion
Series A Prime Preferred Stock
2024-10-15−11,251,624→ 0 total(indirect: By Northpond Ventures II, LP)→ Common Stock (1,003,193 underlying) - Conversion
Series B Preferred Stock
2024-10-15−5,287,303→ 0 total(indirect: By Northpond Ventures, LP)→ Common Stock (471,415 underlying)
Northpond Ventures III GP, LLC
10% Owner
Transactions
- Conversion
Series A Prime Preferred Stock
2024-10-15−11,251,624→ 0 total(indirect: By Northpond Ventures II, LP)→ Common Stock (1,003,193 underlying) - Conversion
Series B Preferred Stock
2024-10-15−5,287,303→ 0 total(indirect: By Northpond Ventures, LP)→ Common Stock (471,415 underlying) - Conversion
Common Stock
2024-10-15+1,003,193→ 1,003,193 total(indirect: By Northpond Ventures II, LP) - Conversion
Common Stock
2024-10-15+471,415→ 471,415 total(indirect: By Northpond Ventures, LP) - Purchase
Common Stock
2024-10-15$11.00/sh+763,636$8,399,996→ 763,636 total(indirect: By Northpond Ventures III, LP)
Northpond Ventures III, LP
10% Owner
Transactions
- Conversion
Common Stock
2024-10-15+1,003,193→ 1,003,193 total(indirect: By Northpond Ventures II, LP) - Conversion
Common Stock
2024-10-15+471,415→ 471,415 total(indirect: By Northpond Ventures, LP) - Conversion
Series A Prime Preferred Stock
2024-10-15−11,251,624→ 0 total(indirect: By Northpond Ventures II, LP)→ Common Stock (1,003,193 underlying) - Purchase
Common Stock
2024-10-15$11.00/sh+763,636$8,399,996→ 763,636 total(indirect: By Northpond Ventures III, LP) - Conversion
Series B Preferred Stock
2024-10-15−5,287,303→ 0 total(indirect: By Northpond Ventures, LP)→ Common Stock (471,415 underlying)
Rubin Michael P.
10% Owner
Transactions
- Conversion
Common Stock
2024-10-15+1,003,193→ 1,003,193 total(indirect: By Northpond Ventures II, LP) - Conversion
Common Stock
2024-10-15+471,415→ 471,415 total(indirect: By Northpond Ventures, LP) - Purchase
Common Stock
2024-10-15$11.00/sh+763,636$8,399,996→ 763,636 total(indirect: By Northpond Ventures III, LP) - Conversion
Series A Prime Preferred Stock
2024-10-15−11,251,624→ 0 total(indirect: By Northpond Ventures II, LP)→ Common Stock (1,003,193 underlying) - Conversion
Series B Preferred Stock
2024-10-15−5,287,303→ 0 total(indirect: By Northpond Ventures, LP)→ Common Stock (471,415 underlying)
Footnotes (4)
- [F1]Each share of Series A Prime Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 11.2158-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
- [F2]The shares are held directly by Northpond Ventures II, LP ("Northpond Fund II"). Northpond Ventures II GP, LLC ("Northpond II GP") is the general partner of Northpond Fund II, and Michael P. Rubin is the managing member of Northpond II GP. As a result, each of Northpond II GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond II GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
- [F3]The shares are held directly by Northpond Ventures, LP ("Northpond Fund I"). Northpond Ventures GP, LLC ("Northpond GP I") is the general partner of Northpond Fund I, and Michael P. Rubin is the managing member of Northpond GP I. As a result, each of Northpond GP I and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund I. Each of Northpond GP I and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
- [F4]The shares are held directly by Northpond Ventures III, LP ("Northpond Fund III"). Northpond Ventures III GP, LLC ("Northpond III GP") is the general partner of Northpond Fund III, and Michael P. Rubin is the managing member of Northpond III GP. As a result, each of Northpond III GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund III. Each of Northpond III GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
Documents
Issuer
Camp4 Therapeutics Corp
CIK 0001736730
Entity typeother
Related Parties
1- filerCIK 0001867627
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 6:34 PM ET
- Size
- 25.4 KB